BPI peptides (XOMA)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameBPI peptides (XOMA)

Drug Alias Nameantiangiogenic compounds (XOMA)BP-300XMP-300

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionAngiogenesis inhibitors

TargetsUpdating

Therapy Area/IndicationsInflammationEye DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesXoma Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesXoma Corp

Active IndicationsN/A

Inactive IndicationsInflammationEye DiseasesNeoplasms

ATC CodeN/A